Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Polarean Imaging's enterprise value is $1.13 Mil.
Polarean Imaging's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 was $-8.83 Mil. Therefore, Polarean Imaging's EV-to-EBITDA for today is -0.13.
The historical rank and industry rank for Polarean Imaging's EV-to-EBITDA or its related term are showing as below:
PLLWF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -28.49 Med: -2.31 Max: 1.44
Current: -0.13
During the past 9 years, the highest EV-to-EBITDA of Polarean Imaging was 1.44. The lowest was -28.49. And the median was -2.31.
PLLWF's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 14.2
vs PLLWF: -0.13
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Polarean Imaging's PE Ratio (TTM) for today is calculated as:
Polarean Imaging's share price for today is $0.0066.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Polarean Imaging's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was $-0.008.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Polarean Imaging's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLLWF vs FOFA, BTCY, LFWD: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Polarean Imaging's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's EV-to-EBITDA falls into.
Polarean Imaging's current Enterprise Value is $1.13 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Polarean Imaging's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 was $-8.83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polarean Imaging (PLLWF) has a EV-to-EBITDA of -0.13 as of Jul. 16, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Polarean Imaging.
Is Polarean Imaging's EV-to-EBITDA too high?
Polarean Imaging's current EV-to-EBITDA is -0.13.
How does Polarean Imaging's EV-to-EBITDA compare to FOFA and BTCY?
Polarean Imaging's EV-to-EBITDA of -0.13 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBITDA is 14.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.20, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Polarean Imaging. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current EV-to-EBITDA is -0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current EV-to-EBITDA of -0.13. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current EV-to-EBITDA is -0.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current EV-to-EBITDA is -0.13 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLLWF has been successfully added to your 
